Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
AKTIENPREIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership5,100 shares
Latest Disclosed Value $ 168,657
Strs Ohio ownership in 354 / Collegium Pharmaceutical, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 5,100 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $140,760 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 5,100 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $132,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 5,100 0 0.00 169 -28.81 0.0007
2026-02-02 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 5,100 0 0.00 236 32.58 0.0009
2025-10-30 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 5,100 5,100 178 0.0007
2025-05-28 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 0 -19,100 -100.00 0 -100.00
2024-11-01 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 19,100 -1,300 -6.37 738 12.50 0.0028
2024-08-05 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 20,400 2,200 12.09 657 0.0026
2024-05-13 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM_STK 19459J104 18,200 11,800 184.38 1 0.0028
2024-01-30 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,400 -14,600 -69.52 0 0.0008
2023-10-26 2023-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 21,000 19,800 1,650.00 0 0.0021
2023-10-26 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 21,000 19,800 0 0.0021
2023-07-31 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 1,200 1,200 0 0.0001
2021-01-25 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -34,000 -100.00 0 -100.00
2020-12-14 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 34,000 0 0.00 707 18.82 0.0030
2020-07-23 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 34,000 3,500 11.48 595 19.48 0.0026
2020-04-23 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 30,500 -5,100 -14.33 498 -31.97 0.0026
2020-01-24 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35,600 -18,900 -34.68 732 17.12 0.0031
2019-10-21 2019-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 54,500 4,800 9.66 625 -4.29 0.0027
2019-10-21 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 54,500 18,900 625 2,766.2847
2019-07-25 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 49,700 9,900 24.87 653 8.47 0.0029
2019-04-19 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 39,800 4,100 11.48 602 -1.63 0.0027
2019-01-23 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 35,700 -15,100 -29.72 612 -18.18 0.0031
2018-10-19 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 50,800 17,300 51.64 748 -6.27 0.0033
2018-08-06 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 33,500 3,900 13.18 798 5.56 0.0034
2018-04-20 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 29,600 29,600 756 0.0033
2017-01-24 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -2,000 -100.00 0 -100.00
2016-10-27 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,000 -100 -4.76 38 58.33 0.0002
2016-07-26 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,100 0 0.00 24 -36.84 0.0001
2016-04-25 2016-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 2,100 0 0.00 38 -33.33 0.0002
2016-01-28 2015-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,100 0 0.00 57 23.91 0.0003
2015-10-21 2015-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,100 0 0.00 46 24.32 0.0002
2015-08-04 2015-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,100 2,100 37 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.